JOP20170147A1 - تركيبات خاصة بالعيون - Google Patents
تركيبات خاصة بالعيونInfo
- Publication number
- JOP20170147A1 JOP20170147A1 JOP/2017/0147A JOP20170147A JOP20170147A1 JO P20170147 A1 JOP20170147 A1 JO P20170147A1 JO P20170147 A JOP20170147 A JO P20170147A JO P20170147 A1 JOP20170147 A1 JO P20170147A1
- Authority
- JO
- Jordan
- Prior art keywords
- epithelial
- induced
- damage induced
- ocular
- ophthalmic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
يتعلق الاختراع الحالي بتركيبة خاصة بالعيون تشتمل على زيت خروع وثلاثي جليسريد ذو سلسلة متوسطة، وباستخدامها في الطب، تحديدا لعلاج و/أو الوقاية من مرض عيني منتقى من المجموعة التي تتكون من جفاف العين، التهاب الملتحمة، التهاب الأدمة، التهاب الجفن، الشتر الداخلي، متلازمة الجفن المترهل، اعتلال العين الدرقي المنشأ، الظفرة، التهاب الملتحمة اللارتخائي، التلف الظهاري المستحث بالمواد الحافظة، تلف الغرفة الظهاري أو السابق المستحث بجراحة العين، خلل الخلية الحوفي، تقرحات القرنية المستحثة بالعوامل الفيزيائية او الكيميائية، التهاب القرنية، التهاب ظاهر الصلبة والتهاب القزحية.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382321.4A EP3266446B1 (en) | 2016-07-07 | 2016-07-07 | Ophthalmic composition comprising castor oil and medium chain triglyceride |
Publications (2)
Publication Number | Publication Date |
---|---|
JOP20170147A1 true JOP20170147A1 (ar) | 2019-01-30 |
JOP20170147B1 JOP20170147B1 (ar) | 2021-08-17 |
Family
ID=56404062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2017/0147A JOP20170147B1 (ar) | 2016-07-07 | 2016-07-07 | تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة |
Country Status (14)
Country | Link |
---|---|
US (1) | US10660848B2 (ar) |
EP (1) | EP3266446B1 (ar) |
JP (1) | JP7224095B2 (ar) |
CN (1) | CN107582605A (ar) |
DK (1) | DK3266446T3 (ar) |
ES (1) | ES2706535T3 (ar) |
HR (1) | HRP20190036T1 (ar) |
JO (1) | JOP20170147B1 (ar) |
LT (1) | LT3266446T (ar) |
PL (1) | PL3266446T3 (ar) |
PT (1) | PT3266446T (ar) |
RS (1) | RS58292B1 (ar) |
RU (1) | RU2756758C2 (ar) |
SI (1) | SI3266446T1 (ar) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018035469A1 (en) | 2016-08-19 | 2018-02-22 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
KR101892865B1 (ko) * | 2017-08-16 | 2018-08-28 | 계명대학교 산학협력단 | 마퀴베리를 유효성분으로 함유하는 아토피성 피부염 예방 또는 치료용 조성물 |
US11622982B2 (en) | 2017-08-18 | 2023-04-11 | Akrivista Llc | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
EP3737363A4 (en) | 2018-01-12 | 2021-10-20 | Metimedi Pharmaceuticals Co., Ltd | METHODS OF TREATMENT OF CHRONIC INFLAMMATORY DISEASES |
KR102556874B1 (ko) * | 2018-02-14 | 2023-07-18 | 동국제약 주식회사 | 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법 |
CN117137866A (zh) * | 2018-02-28 | 2023-12-01 | 参天制药株式会社 | 含有地夸磷索及阳离子性聚合物的眼科用组合物 |
CN113498344A (zh) * | 2018-12-06 | 2021-10-12 | 脂康生命科学有限公司 | 维生素d纳米乳液及其用途 |
JP2022510735A (ja) * | 2018-12-10 | 2022-01-27 | エテルナティアー インコーポレイテッド | 長続きする眼の潤滑をもたらす眼用配合物 |
CN113286581A (zh) * | 2019-01-09 | 2021-08-20 | 扶桑药品工业株式会社 | 用于治疗视网膜疾病的眼内或者口服给药用药物组合物 |
CA3134362A1 (en) * | 2019-04-22 | 2020-10-29 | Hampar L. Karageozian | Compositions and methods useable for treatment of dry eye |
IT201900007202A1 (it) * | 2019-05-24 | 2020-11-24 | Pavia Farm S R L | Composizione a base di vitamine liposolubili ad elevato assorbimento enterico |
RU2706703C1 (ru) * | 2019-08-19 | 2019-11-20 | Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" | Раствор увлажняющий офтальмологический |
GB202010829D0 (en) * | 2020-07-14 | 2020-08-26 | Exonate Ltd | Compounds for treatment of neovascular diseases |
CN111973554A (zh) * | 2020-09-03 | 2020-11-24 | 浙江目中明生物科技有限公司 | 一种护眼水 |
US11951123B2 (en) | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
US11471475B1 (en) | 2022-03-08 | 2022-10-18 | Ralph P. Stone | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery |
US11679078B1 (en) | 2022-03-08 | 2023-06-20 | EternaTear, Inc. | Ophthalmic formulations and related methods |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3102593A1 (de) * | 1981-01-27 | 1982-09-02 | Dr. Thilo & Co GmbH, 8021 Sauerlach | Arzneimittelzubereitung zur anwendung am auge |
JP3410364B2 (ja) * | 1997-05-14 | 2003-05-26 | 千寿製薬株式会社 | ジフルプレドナート含有組成物 |
WO1998053806A1 (fr) * | 1997-05-26 | 1998-12-03 | New Vision Co., Ltd. | Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
FR2823441B1 (fr) * | 2001-04-12 | 2004-09-10 | Thea Lab | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
WO2004098592A1 (ja) * | 2003-05-06 | 2004-11-18 | Senju Pharmaceutical Co. Ltd. | オキサゾリジノン誘導体含有組成物 |
ES2314354T3 (es) * | 2004-11-09 | 2009-03-16 | Novagali Pharma S.A. | Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo. |
CN100478025C (zh) * | 2005-03-25 | 2009-04-15 | 中国科学院上海药物研究所 | 一种环孢菌素a眼用微乳制剂及其制备方法 |
WO2008035246A2 (en) * | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
CN101028240B (zh) * | 2007-03-29 | 2010-06-09 | 中国科学院上海药物研究所 | 眼用微乳/亚微乳原位凝胶制剂及其制备方法 |
US8512687B2 (en) * | 2007-07-09 | 2013-08-20 | Novagali Pharma Sa | Oil in water emulsion comprising NSAIDs and quaternary ammonium halides |
US20100286121A1 (en) * | 2007-11-05 | 2010-11-11 | Rohrs Brian R | Water-Immiscible Materials as Vehicles for Drug Delivery |
CN101385697B (zh) * | 2008-10-30 | 2012-10-03 | 中国科学院上海药物研究所 | 氟比洛芬酯眼用纳米乳-原位凝胶制剂及其制备方法 |
KR101778316B1 (ko) * | 2009-06-05 | 2017-09-13 | 알러간, 인코포레이티드 | 인공 눈물 및 치료학적 용도 |
IT1404931B1 (it) * | 2010-06-11 | 2013-12-09 | Medivis S R L | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . |
CN102370617B (zh) * | 2010-08-13 | 2013-09-11 | 中国科学院上海药物研究所 | 石杉碱甲眼用微乳制剂及其制备方法 |
WO2012091278A2 (ko) * | 2010-12-28 | 2012-07-05 | 한림제약(주) | 나노에멀젼 형태의 안과용 조성물 |
US9610245B2 (en) * | 2011-03-14 | 2017-04-04 | Drug Delivery Solutions Limited | Ophthalmic composition |
JP2013018764A (ja) * | 2011-07-14 | 2013-01-31 | Kao Corp | 上皮型ナトリウムチャネル活性化剤 |
CA2856680C (en) * | 2011-11-24 | 2020-07-14 | Toyo Sugar Refining Co., Ltd. | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder |
PL2787968T3 (pl) | 2011-12-07 | 2020-08-24 | Allergan, Inc. | Wydajne dostarczanie lipidów do ludzkiego filmu łzowego z użyciem wrażliwego na sól układu emulsyjnego |
AU2013257830A1 (en) * | 2012-05-11 | 2014-11-20 | Cipla Limited | Pharmaceutical composition |
JP5084967B1 (ja) * | 2012-06-08 | 2012-11-28 | ライオン株式会社 | 高吸着性ビタミンa含有ナノエマルション粒子を含む眼科用組成物及びその製造方法 |
BR112015014459A2 (pt) * | 2012-12-18 | 2019-12-31 | Univ Keio | agente profilático e terapêutico para olho seco |
EP2968139B1 (en) | 2013-03-14 | 2018-05-23 | Eyecro, LLC | Microemulsion topical delivery platform |
WO2014153733A1 (en) | 2013-03-27 | 2014-10-02 | Comprehensive Drug Enterprises, Ltd. | Ophthalmic composition, method for preparing the same, and use of the same |
KR101492447B1 (ko) * | 2013-05-20 | 2015-02-23 | 주식회사태준제약 | 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법 |
EP3137481B1 (en) * | 2014-05-01 | 2022-07-06 | Integral Biosystems LLC | Membrane-adherent self-assembled systems for treatment of ocular disorders |
CN105496955A (zh) * | 2015-12-11 | 2016-04-20 | 北京蓝丹医药科技有限公司 | 一种二氟泼尼酯眼用乳剂及其制备方法 |
CN105663141B (zh) * | 2016-03-24 | 2018-06-15 | 北京茗泽中和药物研究有限公司 | 二氟泼尼酯眼用乳剂 |
CN105726479B (zh) * | 2016-03-24 | 2018-06-22 | 北京茗泽中和药物研究有限公司 | 环孢素眼用乳剂 |
-
2016
- 2016-07-07 RS RS20190077A patent/RS58292B1/sr unknown
- 2016-07-07 ES ES16382321T patent/ES2706535T3/es active Active
- 2016-07-07 PL PL16382321T patent/PL3266446T3/pl unknown
- 2016-07-07 EP EP16382321.4A patent/EP3266446B1/en active Active
- 2016-07-07 LT LTEP16382321.4T patent/LT3266446T/lt unknown
- 2016-07-07 PT PT16382321T patent/PT3266446T/pt unknown
- 2016-07-07 SI SI201630160T patent/SI3266446T1/sl unknown
- 2016-07-07 JO JOP/2017/0147A patent/JOP20170147B1/ar active
- 2016-07-07 DK DK16382321.4T patent/DK3266446T3/en active
-
2017
- 2017-07-06 RU RU2017123797A patent/RU2756758C2/ru active
- 2017-07-06 JP JP2017132403A patent/JP7224095B2/ja active Active
- 2017-07-07 CN CN201710551883.9A patent/CN107582605A/zh active Pending
- 2017-07-07 US US15/644,286 patent/US10660848B2/en active Active
-
2019
- 2019-01-04 HR HRP20190036TT patent/HRP20190036T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP3266446B1 (en) | 2018-11-21 |
EP3266446A1 (en) | 2018-01-10 |
JP7224095B2 (ja) | 2023-02-17 |
US10660848B2 (en) | 2020-05-26 |
RU2017123797A3 (ar) | 2020-09-18 |
RU2756758C2 (ru) | 2021-10-05 |
RS58292B1 (sr) | 2019-03-29 |
ES2706535T3 (es) | 2019-03-29 |
DK3266446T3 (en) | 2019-02-11 |
SI3266446T1 (sl) | 2019-02-28 |
LT3266446T (lt) | 2019-01-25 |
US20180008538A1 (en) | 2018-01-11 |
CN107582605A (zh) | 2018-01-16 |
JP2018039781A (ja) | 2018-03-15 |
PL3266446T3 (pl) | 2019-05-31 |
RU2017123797A (ru) | 2019-01-09 |
JOP20170147B1 (ar) | 2021-08-17 |
HRP20190036T1 (hr) | 2019-02-22 |
PT3266446T (pt) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20170147A1 (ar) | تركيبات خاصة بالعيون | |
BR112014008759A2 (pt) | tratamento de doença ocular | |
UY30058A1 (es) | (indazol-5-il)-piracinas y (1,3-dihidro-indol-2-on)-piracinas para el tratamiento de enfermedades y afecciones mediadas por la rho quinasa | |
MY171920A (en) | Prevention and treatment of ocular conditions | |
MX2023003124A (es) | Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas. | |
NZ705624A (en) | Compositions and methods for treating ocular edema, neovascularization and related diseases | |
PH12015501938B1 (en) | Ocular formulations for drug-delivery to the posterior segment of the eye | |
EA201790889A1 (ru) | Офтальмологический раствор | |
MY187552A (en) | Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions | |
PH12021550621A1 (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
EA201490721A1 (ru) | Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы | |
NZ746468A (en) | Methods of treating ocular conditions | |
NZ755442A (en) | Topical cyclosporine-containing formulations and uses thereof | |
CL2019002839A1 (es) | Métodos y composiciones para tratar enfermedades asociadas a la retina mediante inhibidores de ccr3. | |
IL273531A (en) | Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases | |
WO2015059122A3 (en) | Sirna and their use in methods and compositions for inhibiting the expression of the orai1 gene | |
EA201990752A1 (ru) | Офтальмологический состав, содержащий цитиколин, переносимый липосомой, для лечения глаукомы | |
EA201891730A1 (ru) | Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности | |
RU2016136333A (ru) | Фармакологическая офтальмологическая композиция, используемая в коррекции пресбиопии, и ее введение | |
CY1111384T1 (el) | Διαμορφωση των επιπεδων εκφρασης toy trpv | |
MX2019011925A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
BR112017014016A2 (pt) | método de redução da pressão intraocular, e, composição farmacêutica. | |
MX2021012960A (es) | Composiciones y metodos de uso de cannabinoides para neuroproteccion. | |
MX350201B (es) | Composiciones oftalmicas con ceras alcoxiladas naturales. | |
CR20170346A (es) | Composiciones para el tratamiento de infecciones producidas por el ácaro demodex spp |